Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Back to Healio Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based therapies and lead to significant weight loss in adults ...

"The body of evidence for the GLP-1 drug class shows that up to 40% of total weight loss in GLP-1 patients is lean body mass including skeletal muscle mass, 1" said Mitchell Glass, M.D., President ...

More research is needed to examine the implications of lean mass loss with GLP-1s. Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized ...

Gad then revealed that he had started taking a GLP-1 for weight loss, and that so far he had ... I'm figuring out this new one, and it is life-changing." However, he also stressed: "But it ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease ... some kinds of cancer and dementia, a sweeping new study suggests. The research also points to important and ...